BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Yan A, Cao W, Shi H, Cao K, Liu X. Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma. Cancer Cell Int 2020;20:584. [PMID: 33372609 DOI: 10.1186/s12935-020-01670-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Yu D, Zhou H, Zhang X, Hu Y, Zhang R, Gao X, Lin M, Guo T, Zhang K. The role of EphA7 in different tumors. Clin Transl Oncol 2022;24:1274-89. [PMID: 35112312 DOI: 10.1007/s12094-022-02783-1] [Reference Citation Analysis]
2 Park B, Heo SJ, Lee YJ, Seo MK, Hong J, Shin EC, Jung I, Kim S. HLA-I-restricted CD8+ T cell immunity may accelerate tumorigenesis in conjunction with VHL inactivation. iScience 2022;25:104467. [PMID: 35677644 DOI: 10.1016/j.isci.2022.104467] [Reference Citation Analysis]
3 Seliger B, Massa C. Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways. Front Immunol 2022;13:883639. [PMID: 35663987 DOI: 10.3389/fimmu.2022.883639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang G, Zhang L, Sun S, Chen M. Identification of a Novel Defined Immune-Autophagy-Related Gene Signature Associated With Clinical and Prognostic Features of Kidney Renal Clear Cell Carcinoma. Front Mol Biosci 2021;8:790804. [PMID: 34988121 DOI: 10.3389/fmolb.2021.790804] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Tong Y, Yu Y, Zheng H, Wang Y, Xie S, Chen C, Lu R, Guo L. Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures. Front Oncol 2021;11:776824. [PMID: 34976818 DOI: 10.3389/fonc.2021.776824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tong D, Zhang Y, Jiang J, Bi G. Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype-phenotype correlation and gene therapy perspective. Cancer Cell Int 2021;21:685. [PMID: 34923986 DOI: 10.1186/s12935-021-02386-w] [Reference Citation Analysis]
7 Wu S, Li X. A genomic instability-derived risk index predicts clinical outcome and immunotherapy response for clear cell renal cell carcinoma. Bioengineered 2021;12:1642-62. [PMID: 33955826 DOI: 10.1080/21655979.2021.1922330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]